// App-Quantinova.ai

BSH2020‐EP‐114 : Osteonecrosis of the jaw secondary to bisphosphonate treatment in multiple myeloma – real‐world data

Researchers

Presenter

  • L. Vanhinsbergh

Principal Investigators

  • J. Husain

Medical Centers

  • Rheumatology, UCL, London, UK

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Nephrology

  • Oncology (ONC)

Disease

  • Multiple Myeloma

  • Renal insufficiency

Biomarkers

  • N/A

Drug/Treatment

  • Zoledronic acid

  • Zolendronic acid

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved